Leo Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Leo Pharma
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€615,360
2024 · €684,266-€68,907
Equity
€9.9m
2024 · €9.3m+€615,360
Cash
-
not filed
Balance sheet total
€15.1m
2024 · €12.1m+€2.9m
Largest movements
Assets
- Receivables within one year +€4.1m
up €4.1m (+68.2%), from €6.0m to €10.1m
of which Other amounts receivable: +€4.4m
- Stocks and contracts -€1.3m
down €1.3m (-20.9%), from €6.0m to €4.7m
Equity and liabilities
- Trade debts +€2.6m
up €2.6m (+183.6%), from €1.4m to €4.1m
- Profit (loss) carried forward +€615,360
up €615,360 (+7.1%), from €8.6m to €9.3m
- Tax, wage and social debts -€291,761
down €291,761 (-22.6%), from €1.3m to €998,721
of which Remuneration and social security: -€298,178
Income statement
- Turnover -€1.8m
down €1.8m (-5.4%), from €33.9m to €32.1m
- Staff costs -€1.1m
down €1.1m (-23.1%), from €4.9m to €3.8m
- Goods and materials -€348,381
down €348,381 (-1.8%), from €19.0m to €18.7m
of which Purchases: -€2.2m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€684,266
Turnover
-€1.8m
Other operating income
+€246,304
Goods and materials
+€348,381
Services and other goods
-€103,126
Staff costs
+€1.1m
Depreciation
+€4,717
Other operating charges
+€152,212
Financial income
-€44,849
Financial charges
+€3,864
Taxes
+€19,269
Result 2025
€615,360
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €12,145,020 | €15,052,134 | +€2.9m | +23.9% |
| Fixed assets | 21/28 | €151,853 | €145,493 | -€6,359 | -4.2% |
| Intangible fixed assets | 21 | €77,522 | €69,362 | -€8,160 | -10.5% |
| Tangible fixed assets | 22/27 | €34,861 | €36,662 | +€1,801 | +5.2% |
| Plant, machinery and equipment | 23 | €34,861 | €36,662 | +€1,801 | +5.2% |
| Financial fixed assets | 28 | €39,470 | €39,470 | = | 0.0% |
| Other financial fixed assets | 284/8 | €39,470 | €39,470 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €39,470 | €39,470 | = | 0.0% |
| Current assets | 29/58 | €11,993,168 | €14,906,641 | +€2.9m | +24.3% |
| Stocks and contracts in progress | 3 | €5,997,190 | €4,743,386 | -€1.3m | -20.9% |
| Stocks | 30/36 | €5,997,190 | €4,743,386 | -€1.3m | -20.9% |
| Goods purchased for resale | 34 | €5,997,190 | €4,743,386 | -€1.3m | -20.9% |
| Amounts receivable within one year | 40/41 | €5,995,978 | €10,083,255 | +€4.1m | +68.2% |
| Trade receivables | 40 | €5,234,731 | €4,968,842 | -€265,888 | -5.1% |
| Other amounts receivable | 41 | €761,247 | €5,114,413 | +€4.4m | +571.8% |
| Deferred charges and accrued income | 490/1 | - | €80,000 | +€80,000 | |
| Total equity and liabilities | 10/49 | €12,145,020 | €15,052,134 | +€2.9m | +23.9% |
| Equity | 10/15 | €9,319,104 | €9,934,463 | +€615,360 | +6.6% |
| Contributions | 10/11 | €644,523 | €644,523 | = | 0.0% |
| Capital | 10 | €272,683 | €272,683 | = | 0.0% |
| Issued capital | 100 | €272,683 | €272,683 | = | 0.0% |
| Outside capital | 11 | €371,840 | €371,840 | = | 0.0% |
| Share premium | 1100/10 | €371,840 | €371,840 | = | 0.0% |
| Reserves | 13 | €27,268 | €27,268 | = | 0.0% |
| Non-distributable reserves | 130/1 | €27,268 | €27,268 | = | 0.0% |
| Legal reserve | 130 | €27,268 | €27,268 | = | 0.0% |
| Profit (loss) carried forward | 14 | €8,647,312 | €9,262,672 | +€615,360 | +7.1% |
| Amounts payable | 17/49 | €2,825,916 | €5,117,671 | +€2.3m | +81.1% |
| Amounts payable within one year | 42/48 | €2,724,098 | €5,062,184 | +€2.3m | +85.8% |
| Trade debts | 44 | €1,432,455 | €4,062,299 | +€2.6m | +183.6% |
| Suppliers | 440/4 | €1,432,455 | €4,062,299 | +€2.6m | +183.6% |
| Taxes, remuneration and social security | 45 | €1,290,483 | €998,721 | -€291,761 | -22.6% |
| Taxes | 450/3 | €251,133 | €257,550 | +€6,417 | +2.6% |
| Remuneration and social security | 454/9 | €1,039,350 | €741,171 | -€298,178 | -28.7% |
| Other amounts payable | 47/48 | €1,160 | €1,163 | +€3 | +0.3% |
| Accrued charges and deferred income | 492/3 | €101,818 | €55,486 | -€46,332 | -45.5% |
| Operating income | 70/76A | €33,917,963 | €32,327,993 | -€1.6m | -4.7% |
| Turnover | 70 | €33,908,105 | €32,071,831 | -€1.8m | -5.4% |
| Other operating income | 74 | €9,859 | €256,163 | +€246,304 | +2498.4% |
| Operating charges | 60/66A | €33,072,028 | €31,529,248 | -€1.5m | -4.7% |
| Goods for resale, raw materials and consumables | 60 | €19,038,149 | €18,689,768 | -€348,381 | -1.8% |
| Purchases | 600/8 | €19,615,938 | €17,435,964 | -€2.2m | -11.1% |
| Change in stocks: decrease (increase) | 609 | -€577,789 | €1,253,804 | +€1.8m | |
| Services and other goods | 61 | €3,382,420 | €3,485,546 | +€103,126 | +3.0% |
| Remuneration, social security and pensions | 62 | €4,931,964 | €3,791,368 | -€1.1m | -23.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €21,064 | €16,348 | -€4,717 | -22.4% |
| Other operating charges | 640/8 | €5,698,430 | €5,546,219 | -€152,212 | -2.7% |
| Operating profit (loss) | 9901 | €845,935 | €798,745 | -€47,190 | -5.6% |
| Financial income | 75/76B | €160,318 | €115,470 | -€44,849 | -28.0% |
| Recurring financial income | 75 | €160,318 | €115,470 | -€44,849 | -28.0% |
| Income from current assets | 751 | €159,401 | €115,065 | -€44,336 | -27.8% |
| Other financial income | 752/9 | €918 | €404 | -€513 | -55.9% |
| Financial charges | 65/66B | €9,247 | €5,384 | -€3,864 | -41.8% |
| Recurring financial charges | 65 | €9,247 | €5,384 | -€3,864 | -41.8% |
| Debt charges | 650 | - | €488 | +€488 | |
| Other financial charges | 652/9 | €9,247 | €4,895 | -€4,352 | -47.1% |
| Profit (loss) for the period before taxes | 9903 | €997,006 | €908,831 | -€88,176 | -8.8% |
| Income taxes | 67/77 | €312,740 | €293,471 | -€19,269 | -6.2% |
| Taxes | 670/3 | €312,740 | €293,471 | -€19,269 | -6.2% |
| Tax adjustments and reversals of tax provisions | 77 | €0 | - | = | |
| Profit (loss) for the period | 9904 | €684,266 | €615,360 | -€68,907 | -10.1% |
| Profit (loss) for the period to be appropriated | 9905 | €684,266 | €615,360 | -€68,907 | -10.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.